Sphera Funds Management’s Aevi Genomic Medicine Inc GNMX Stock Holding History

Sphera Funds Management’s Portfolio GNMX Stock Details GNMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-405,000	Closed	-$753K	–	153
2017 Q1	$753K	Sell	405,000 -45,000	-10%	-$204K	0.19%	97
2016 Q4	$2.33M	Hold	450,000	–	–	0.72%	50
2016 Q3	$2.51M	Hold	450,000	–	–	0.58%	63
2016 Q2	$2.5M	Buy	+450,000	New	+$2.36M	0.7%	48
2015 Q2	–	Sell	-175,000	Closed	-$1.41M	–	174
2015 Q1	$1.41M	Sell	175,000 -50,000	-22%	-$377K	0.2%	124
2014 Q4	$1.14M	Buy	+225,000	New	+$1.11M	0.2%	106

Other funds holding GNMX

Adage Capital Partners

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management

Millennium Management New York $134B AUM 35.51% 1-Year Est. Return

22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return

Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

Element Capital Management New York $255M AUM 5.05% 1-Year Est. Return